Analysis of patients with atypical hemolytic uremic syndrome treated at the Mie University Hospital: concentration of C3 p.I1157T mutation von Matsumoto, Takeshi, Fan, Xinping, Ishikawa, Eiji, Ito, Masaaki, Amano, Keishirou, Toyoda, Hidemi, Komada, Yoshihiro, Ohishi, Kohshi, Katayama, Naoyuki, Yoshida, Yoko, Matsumoto, Masanori, Fujimura, Yoshihiro, Ikejiri, Makoto, Wada, Hideo, Miyata, Toshiyuki

Volltext

Heterogeneity of neuroblastoma cell lines in insulin‐like growth factor 1 receptor/Akt pathway‐mediated cell proliferative responses von Qi, Lei, Toyoda, Hidemi, Shankar, Vipin, Sakurai, Naoto, Amano, Keishirou, Kihira, Kentaro, Iwasa, Tadashi, Deguchi, Takao, Hori, Hiroki, Azuma, Eiichi, Gabazza, Esteban C., Komada, Yoshihiro

Volltext

Clinical Manifestation of Patients With Atypical Hemolytic Uremic Syndrome With the C3 p.I1157T Variation in the Kinki Region of Japan von Matsumoto, Takeshi, Toyoda, Hidemi, Amano, Keishirou, Hirayama, Masahiro, Ishikawa, Eiji, Fujimoto, Mika, Ito, Masaaki, Ohishi, Kohshi, Katayama, Naoyuki, Yoshida, Yoko, Matsumoto, Masanori, Kawamura, Naohisa, Ikejiri, Makoto, Kawakami, Keiki, Miyata, Toshiyuki, Wada, Hideo

Volltext

PDK1-mTOR signaling pathway inhibitors reduce cell proliferation in MK2206 resistant neuroblastoma cells von Qi, Lei, Toyoda, Hidemi, Xu, Dong-Qing, Zhou, Ye, Sakurai, Naoto, Amano, Keishirou, Kihira, Kentaro, Hori, Hiroki, Azuma, Eiichi, Komada, Yoshihiro

Volltext

Erratum to: PDK1-mTOR signaling pathway inhibitors reduce cell proliferation in MK2206 resistant neuroblastoma cells von Qi, Lei, Toyoda, Hidemi, Xu, Dong-Qing, Zhou, Ye, Sakurai, Naoto, Amano, Keishirou, Kihira, Kentaro, Hori, Hiroki, Azuma, Eiichi, Komada, Yoshihiro

Volltext